A systematic review of coverage decision-making on health technologies—Evidence from the real world
- 4 August 2012
- journal article
- review article
- Published by Elsevier in Health Policy
- Vol. 107 (2-3) , 218-230
Abstract
No abstract availableKeywords
This publication has 61 references indexed in Scilit:
- Role of centralized review processes for making reimbursement decisions on new health technologies in EuropeClinicoEconomics and Outcomes Research, 2011
- What principles should govern the use of managed entry agreements?International Journal of Technology Assessment in Health Care, 2011
- Comparative Effectiveness Research and Evidence‐Based Health Policy: Experience from Four CountriesThe Milbank Quarterly, 2009
- Clearing up the hazy road from bench to bedside: A framework for integrating the fourth hurdle into translational medicineBMC Health Services Research, 2008
- Value based pricing for NHS drugs: an opportunity not to be missed?BMJ, 2008
- Single Technology Appraisals by NICEPharmacoEconomics, 2008
- Review of NICE's recommendations, 1999-2005BMJ, 2006
- Priority setting for pharmaceuticalsThe European Journal of Health Economics, 2004
- Cost-Effectiveness Analysis and the Consistency of Decision MakingPharmacoEconomics, 2001
- Using Economic Evaluations to Make Formulary Coverage DecisionsPharmacoEconomics, 2000